Delivery Order SPE2DB20D3103-SPE2DB22FP9B1

Award Date 9/15/22
Potential Completion Date 9/16/22
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $1,431.80, is a Firm Fixed Price Delivery Order for the procurement of ETONOGESTREL-EE VAGINAL RINGS. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,613.98 firm fixed-price delivery order is for the supply of Etonogestrel-EE Vaginal Rings, a specialized medical product. The contract has an ultimate completion date of August 26, 2022 and was awarded on August 25, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $1,584.65, is for the delivery of ETONOGESTREL-EE VAGINAL RINGS, a type of medical product. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Etonogestrel-EE vaginal rings. The contract, valued at $1,182.28, is a firm fixed-price delivery order with a completion date of June 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Etonogestrel-EE vaginal rings. The contract has a firm fixed price of $1,333.28 and a completion date of May 17, 2023. The award is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,690.10 firm fixed-price delivery order is for the procurement of ETONOGESTREL-EE VAGINAL RINGS. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ETONOGESTREL-EE VAGINAL RINGS to the Defense Logistics Agency (DLA). The contract, valued at $1,313.82, is a firm fixed-price delivery order that runs through June 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,188.28 firm-fixed-price delivery order is for etonogestrel-EE vaginal rings, with a completion date of August 7, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.45 firm fixed-price delivery order is for the supply of ETONOGESTREL-EE VAGINAL RINGS, a medical product. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $4,935.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Etonogestrel-EE Vaginal Rings, a medical product used in healthcare applications. This is a firm fixed-price delivery order contract, with a completion date of March 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP9B1
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of Etonogestrel-EE vaginal rings. The contract has a firm fixed price of $1,448.52 and an ultimate completion date of September 16, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:38 PM